Mechanisms of metabolic reprogramming in cancer cells supporting enhanced growth and proliferation
C Schiliro, BL Firestein - Cells, 2021 - mdpi.com
Cancer cells alter metabolic processes to sustain their characteristic uncontrolled growth
and proliferation. These metabolic alterations include (1) a shift from oxidative …
and proliferation. These metabolic alterations include (1) a shift from oxidative …
Combined cytotoxic chemotherapy and immunotherapy of cancer: modern times
Monoclonal antibodies targeting programmed cell death 1/programmed cell death ligand 1
(PD-1/PD-L1) immune checkpoints have improved the treatments of cancers. However, not …
(PD-1/PD-L1) immune checkpoints have improved the treatments of cancers. However, not …
Post-ingestion conversion of dietary indoles into anticancer agents
LP Lin, D Liu, JC Qian, L Wu, Q Zhao… - National Science …, 2022 - academic.oup.com
There are health benefits from consuming cruciferous vegetables that release indole-3-
carbinol (I3C), but the in vivo transformation of I3C-related indoles remains …
carbinol (I3C), but the in vivo transformation of I3C-related indoles remains …
[HTML][HTML] Folate, folic acid, and chemotherapy-induced toxicities: A systematic literature review
NRK Zwart, MD Franken, WJE Tissing… - Critical reviews in …, 2023 - Elsevier
Folate metabolism is a target for various chemotherapeutic drugs. Folate and its synthetic
variant folic acid are B-vitamins. To what extent these vitamins impact treatment tolerance in …
variant folic acid are B-vitamins. To what extent these vitamins impact treatment tolerance in …
Metabolomics in oncology
Background Oncogenic transformation alters intracellular metabolism and contributes to the
growth of malignant cells. Metabolomics, or the study of small molecules, can reveal insight …
growth of malignant cells. Metabolomics, or the study of small molecules, can reveal insight …
Pemetrexed ameliorates Con A-induced hepatic injury by restricting M1 macrophage activation
Z Liu, Z Bao, B Yu, L Chen, G Yang - International Immunopharmacology, 2023 - Elsevier
Autoimmune hepatitis (AIH), characterized by immune-driven liver destruction and cytokine
production, is a progressive inflammatory liver condition that may progress to hepatic …
production, is a progressive inflammatory liver condition that may progress to hepatic …
A rare case of pemetrexed-induced diffuse punctal and canalicular stenosis: management by coronary balloon puncto-canaliculoplasty
A Sharma, M Pattnaik, MJ Ali - Orbit, 2022 - Taylor & Francis
Several chemotherapeutic agents are known to induce lacrimal drainage stenosis and
obstruction, resulting in epiphora. Pemetrexed is one such drug and is used in the …
obstruction, resulting in epiphora. Pemetrexed is one such drug and is used in the …
Preparation and Evaluation of Stearylamine-Bearing Pemetrexed Disodium-Loaded Cationic Liposomes In Vitro and In Vivo
K He, J Liu, Y Gao, Y Hao, X Yang, G Huang - AAPS PharmSciTech, 2020 - Springer
Pemetrexed disodium (PMX) stands out in the treatment of non-small cell lung cancer
(NSCLC), but with short half-life and toxic side effects. This study was to design cationic …
(NSCLC), but with short half-life and toxic side effects. This study was to design cationic …
Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 …
X Han, L Chen, Z Hu, L Chen, P Sun, Y Wang… - Journal of Proteomics, 2021 - Elsevier
Abstract Pemetrexed (PEM), a multi-target folate antagonist, has been extensively used for
the treatment of non-small cell lung cancer (NSCLC). However, the therapeutic efficacy of …
the treatment of non-small cell lung cancer (NSCLC). However, the therapeutic efficacy of …
GSK3β inhibition prevents macrophage reprogramming by high-dose methotrexate
I Ríos, B López-Navarro, M Torres-Torresano… - Journal of innate …, 2023 - karger.com
Methotrexate (MTX) is an antifolate drug used as a chemotherapeutic agent for acute
lymphoblastic leukemia, where MTX improves patients' prognosis. Macrophage …
lymphoblastic leukemia, where MTX improves patients' prognosis. Macrophage …